About BioInquire
BioInquire is a Healthcare company based in Athens (United States) founded in 2006, and was acquired by NuSep in December 2009. Software for proteomics data analysis and quantification is developed. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Cyrus Biotechnology, Vividion Therapeutics and Seer; 3 of its 3 listed competitors have raised funding.
Company details
BioInquire was founded in 2006 in Athens, United States, and focuses on software solutions for the life sciences sector. ProteoIQ is offered as a platform for processing proteomics data, including validation, organization, and interrogation of results. The tool covers the full analysis pipeline, from statistical validation to quantitative assessment, aiding scientific discovery in comparative proteomics.
- Headquarters Athens, United States
- Stage Acquired
- SectorsHealthcare
- Website bioinquire.com
- Social LinkedIn
- Acquired by NuSep (Dec 2009)
Funding Insights of BioInquire
- Total Rounds 4
- Last Round Grant — $199,980
- First Round $847,364
(Jan 2008)
- Investors Count 1
All 4 funding rounds of BioInquire with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in BioInquire
BioInquire has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and NuSep.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Provides protein visualization and analysis tools for research and biopharma applications. | 2006 | nusep.com | Germantown, United States |
Investor details for BioInquire
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BioInquire
4 dated milestones of BioInquire across 3 years, from founding to its latest funding, stage changes and deals.
- Founded BioInquire is founded.
- Funding First funding round of $847K.
- Funding Latest funding round, Grant, of $200K.
- Exit Acquired by NuSep.
Competitors of BioInquire
BioInquire has 3 listed competitors in our database, 3 of them funded. They include Cyrus Biotechnology, Vividion Therapeutics and Seer.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cyrusbio.com | 2014 | Seattle, United States | $31.99M | 23 | Cloud-based protein-modeling software is developed for drug discovery. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| seer.bio | 2017 | San Francisco, United States | $127.5M | 89 | Proteomics platform developed for early cancer and neurological disease detection. |
Detailed competitors of BioInquire
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioInquire
Websites that share an audience with BioInquire (bioinquire.com).
Websites whose visitors overlap most with BioInquire. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| matrixscience.com | 100% | #1,101,180 | View details | ||
| proteomics.com.au | 99% | 6K | #3,704,964 | View details | |
biosoftsolutions.de | biosoftsolutions.de | 99% | – | ||
sharedproteomics.com | sharedproteomics.com | 98% | – | ||
proteomicworld.org | proteomicworld.org | 98% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for BioInquire
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as BioInquire (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioInquire
BioInquire was founded in 2006 and raised its 1st funding round 2 years after it was founded.
BioInquire is headquartered in Athens, United States.
BioInquire was founded in 2006 in Athens, United States, and focuses on software solutions for the life sciences sector. ProteoIQ is offered as a platform for processing proteomics data, including validation, organization, and interrogation of results. The tool covers the full analysis pipeline, from statistical validation to quantitative assessment, aiding scientific discovery in comparative proteomics.
BioInquire's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Seer.
Yes. BioInquire was acquired by NuSep in December 2009.